fungal pathogenesis – Page 11

Things you wanted to know about fungal extracellular vesicles (but were afraid to ask)

mycolabadmin

Fungal extracellular vesicles are tiny particles released by fungal cells that play important roles in how fungi cause disease and how our immune system responds. These particles can either help fight infections or make them worse depending on the type of fungus and conditions involved. Scientists are discovering that these vesicles could potentially be used as vaccines and may explain why some antifungal drugs stop working.

First case of fungemia caused by a rare and pan-echinocandin resistant yeast Sporopachydermia lactativora in China

mycolabadmin

A 37-year-old woman with leukemia developed a rare blood infection caused by a yeast called Sporopachydermia lactativora, which had never been documented to cause bloodstream infection in China before. This yeast is naturally resistant to a common class of antifungal drugs called echinocandins, making it particularly challenging to treat. However, the patient responded well to a different antifungal medication called voriconazole and fully recovered. The researchers suggest that this unusual yeast should be monitored in hospitals as it could become a more common infection in vulnerable patients.

Impact of Oxalic Acid Consumption and pH on the In Vitro Biological Control of Oxalogenic Phytopathogen Sclerotinia sclerotiorum

mycolabadmin

This research shows how bacteria can protect crops from a destructive fungus called Sclerotinia sclerotiorum. While scientists previously thought the bacteria worked by eating the toxic acid produced by the fungus, this study reveals that the bacteria also make the environment more alkaline (less acidic), which the fungus cannot tolerate. The combination of both effects—consuming the acid and changing the pH—is what actually stops the fungus from growing and damaging crops.

Gene transfer between fungal species triggers repeated coffee wilt disease outbreaks

mycolabadmin

A new study found that coffee wilt disease, which has caused major crop losses in Africa, has repeatedly emerged due to genes jumping between different fungal species. These genes travel via special mobile DNA elements called Starships, which act like genetic vehicles carrying pathogenic genes from one fungus to another. When Fusarium fungi exchanged genes this way, they became better at infecting different varieties of coffee plants. Understanding how these genes move is crucial for protecting coffee crops from future disease outbreaks.

Mechanisms of Talaromyces marneffei induced CNS injury: Synergistic roles of tauopathy, pyroptosis, and microglial inflammation

mycolabadmin

A dangerous fungus called Talaromyces marneffei can invade the brain and cause serious damage in people with weakened immune systems. The study shows the fungus harms brain cells through two pathways: direct damage to neurons and indirect damage through activation of brain immune cells that release harmful inflammatory chemicals. Understanding these mechanisms could help develop better treatments for this life-threatening infection.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Mucormycosis is a serious fungal infection that primarily affects people with weak immune systems and carries high mortality rates. Researchers studied three common mucormycosis-causing fungi to understand how their outer cell layers interact with the human immune system. They found that all three fungi trigger strong inflammatory responses, which may explain why the disease is so damaging. This research helps us better understand how these infections work and could lead to improved treatments or vaccines.

Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies

mycolabadmin

This editorial highlights the growing problem of fungal infections that resist current treatments, causing millions of deaths worldwide each year. Researchers are finding new ways to fight these resistant infections by repurposing existing drugs in new combinations and discovering novel compounds from natural sources. The collection of studies presented shows promising results using combinations like minocycline with antifungal drugs, natural compounds like baicalin, and AI technology to predict resistance patterns. These innovative approaches offer hope for better treatment options for patients suffering from serious fungal infections.

The expression of fungal CotH, human glucose-regulated protein 78 (GRP78), and predicted miRNAs in macrophages and diabetic mice infected with Rhizopus oryzae

mycolabadmin

Mucormycosis is a serious fungal infection caused by Rhizopus oryzae that is particularly dangerous for people with diabetes. This study shows that a fungal protein called CotH3 attaches to a human cell receptor called GRP78, allowing the fungus to invade cells more easily in diabetic patients. The research found that diabetes increases GRP78 production, making fungal invasion more likely, while antifungal treatment (liposomal amphotericin B) can reduce the expression of both CotH3 and GRP78.

Effects of simulated microgravity on biological features and virulence of the fungal pathogen Cryptococcus neoformans

mycolabadmin

Scientists studied how a dangerous fungus called Cryptococcus neoformans behaves in space-like conditions. They found that in simulated microgravity, the fungus becomes more dangerous by developing thicker protective capsules and producing more melanin, while also becoming more resistant to certain stresses. Interestingly, the fungus became more sensitive to one antifungal drug but maintained resistance to others. When tested on microscopic worms, the fungus grown in simulated microgravity killed them more quickly, suggesting space conditions could make this fungus more harmful to astronauts.

Characterization of ORF19.7608 (PPP1), a biofilm-induced gene of Candida albicans

mycolabadmin

Researchers studied a gene called PPP1 in Candida albicans, a common fungal infection in hospitals. They found that this gene is highly active when the fungus forms protective biofilms on medical devices like catheters. Although the protein appears in a distinctive spotted pattern only during biofilm formation, removing this gene did not prevent biofilm formation or affect how the fungus responds to stress or antifungal drugs.

Research Topic: fungal pathogenesis